|
1
|
Duwe BV, Sterman DH and Musani AI: Tumors
of the mediastinum. Chest. 128:2893–2909. 2005.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Yoneda KY, Louie S and Shelton DK:
Mediastinal tumors. Curr Opin Pulm Med. 7:226–233. 2001.
|
|
3
|
Kern JA, Deniel TN, Trible CG, Silen ML
and Rodgers BM: Thoracoscopic diagnosis and treatment of
mediastinal masses. Ann Thorac Surg. 56:92–96. 1993.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Rendina EA, Venuta F, De Giacomo T,
Ciriaco PP, Pescarmona EO, Francioni F, Pulsoni A, Malagnino F and
Ricci C: Comparative merits of thoracoscopy, mediastinoscopy, and
mediastinotomy for mediastinal biopsy. Ann Thorac Surg. 57:992–995.
1994.PubMed/NCBI View Article : Google Scholar
|
|
5
|
David SE, Gregory JR and Wallace A: NCCN
Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
Thymomas and Thymic Carcinomas. J Natl Compr Cancer Netw.
11:562–576. 2013.
|
|
6
|
Tomiyama N, Honda O, Tsubamoto M, Inoue A,
Sumikawa H, Kuriyama K, Kusumoto M, Johkoh T and Nakamura H:
Anterior mediastinal tumors: Diagnostic accuracy of CT and MRI. Eur
J Radiol. 69:280–288. 2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sakai S, Murayama S, Soeda H, Matsuo Y,
Ono M and Masuda K: Differential diagnosis between thymoma and
non-thymoma by dynamic MR imaging. Acta Radiol. 43:262–268.
2002.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Endo M, Nakagawa K, Ohde Y, Okumura T,
Kondo H, Igawa S, Nakamura Y, Tsuya A, Murakami H, Takahashi T, et
al: Utility of 18FDG-PET for differentiating the grade
of malignancy in thymic epithelial tumors. Lung Cancer. 61:350–355.
2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Terzi A, Bertolaccini L, Rizzardi G, Luzzi
L, Bianchi A, Campione A, Comino A and Biggi A: Usefulness of 18-F
FDG PET/CT in the pre-treatment evaluation of thymic epithelial
neoplasms. Lung Cancer. 74:239–243. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lococo F, Cesario A, Okami J, Cardillo G,
Cavuto S, Tokunaga T, Apolone G, Margaritora S and Granone P: Role
of combined18F-FDG-PET/CT for predicting the WHO
malignancy grade of thymic epithelial tumors: A multicenter
analysis. Lung Cancer. 82:245–251. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Igai H, Matsuura N, Tarumi S, Chang SS,
Misaki N, Go T, Ishikawa S and Yokomise H: Usefulness of
[18F]fluoro-2-deoxy-D-glucose positron emission
tomography for predicting the world health organization malignancy
grade of thymic epithelial tumors. Eur J Cardiothorac Surg.
40:143–145. 2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Otsuka H: The utility of FDG-PET in the
diagnosis of thymic epithelial tumors. J Med Invest. 59:225–234.
2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Luzzi L, Campione A, Gorla A, Vassallo G,
Bianchi A, Biggi A and Terzi A: Role of fluorine-flurodeoxyglucose
positron emission tomography/computed tomography in preoperative
assessment of anterior mediastinal masses. Eur J Cardiothorac Surg.
36:475–479. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Shibata H, Nomori H, Uno K, Sakaguchi K,
Nakashima R, Iyama K, Tomiyoshi K, Kaji M, Goya T, Suzuki T and
Horio H: 18F-fluorodeoxyglucose and
11C-acetate positron emission tomography are useful
modalities for diagnosing the histologic type of thymoma. Cancer.
115:2531–2538. 2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kaira K, Sunaga N, Ishizuka T, Shimizu K
and Yamamoto N: The role of [18F]fluorodeoxyglucose
positron emission tomography in thymic epithelial tumors. Cancer
Imaging. 11:195–201. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Toba H, Kondo K, Sadohara Y, Otsuka H,
Morimoto M, Kajiura K, Nakagawa Y, Yoshida M, Kawakami Y, Takizawa
H, et al: 18F-fluorodeoxyglucose positron emission
tomography/computed tomography and the relationship between
fluorodeoxyglucose uptake and the expression of hypoxia-inducible
factor-1α, glucose transporter-1 and vascular endothelial growth
factor in thymic epithelial tumours. Eur J Cardiothorac Surg.
44:e105–e112. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Fukumoto K, Taniguchi T, Ishikawa Y,
Kawaguchi K, Fukui T, Kato K, Matsuo K and Yokoi K: The utility of
[18F]-fluorodeoxyglucose positron emission
tomography-computed tomography in thymic epithelial tumours. Eur J
Cardiothorac Surg. 42:e152–e156. 2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Sung YM, Lee KS, Kim BT, Choi JY, Shim YM
and Yi CA: 18F-FDG PET/CT of thymic epithelial tumors:
Usefulness for distinguishing and staging tumor subgroups. J Nucl
Med. 47:1628–1634. 2006.PubMed/NCBI
|
|
19
|
Seki N, Sakamoto S, Karube Y, Oyaizu T,
Ishihama H and Chida M: 18F-fluorodeoxyglucose positron
emission tomography for evaluation of thymic epithelial tumors:
Utility for world health organization classification and predicting
recurrence-free survival. Ann Nucl Med. 28:257–262. 2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yajima T, Mogi A, Shimizu K, Kosaka T,
Ohtaki Y, Obayashi K, Nakazawa S, Nakajima T, Tsushima Y and
Shirabe K: Quantitative analysis of metabolic parameters at
18F-fluorodeoxyglucose positron emission tomography in
predicting malignant potential of anterior mediastinal tumors.
Oncol Lett. 19:1865–1871. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kitami A, Sano F, Ohashi S, Suzuki K,
Uematsu S, Suzuki T and Kadokura M: The usefulness of
positron-emission tomography findings in the management of anterior
mediastinal tumors. Ann Thorac Cardiovasc Surg. 23:26–30.
2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
McErlean A, Huang J, Zabor EC, Moskowitz
CS and Ginsberg MS: Distinguishing benign thymic lesions from
early-stage thymic malignancies on computed tomography. J Thorac
Oncol. 8:967–973. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Priola SM, Priola AM, Cardinale L, Perotto
F and Fava C: The anterior mediastinum: Anatomy and imaging
procedures. Radiol Med. 111:295–311. 2006.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Priola AM, Priola SM, Giraudo MT, Gned D,
Fornari A, Ferrero B, Ducco L and Veltri A: Diffusion-weighted
magnetic resonance imaging of thymoma: Ability of the apparent
diffusion coefficient in predicting the world health organization
(WHO) classification and the Masaoka-Koga staging system and its
prognostic significance on disease-free survival. Eur Radiol.
26:2126–2138. 2016.PubMed/NCBI View Article : Google Scholar
|
